NCT05696223

Brief Summary

When a FGR is diagnose, the challenge in his monitoring is to assess the benefit-risk balance between continuing the pregnancy in order to limit complications related to prematurity and birth in order to minimize any risk of fetal death in utero. By able to know the characteristics of fetal deteriorations and its relationship with fetal and neonatal outcomes could be a thankful help in this decision. The placental insufficiency is by far the most common cause of FGR (32)(miller 2008). This effect can be documented thanks to ultrasound examinations to study fetal growth and Doppler of umbilical arteries for the placenta, the middle cerebral artery for the brain perfusion and the Ductus Venosus for the cardiac effects of placental dysfunction. The apparition of Doppler abnormalities suggests a deterioration of the disease and leads to several changes in clinical FGR management. Nevertheless, at this time, very few studies allow us to predict the time util the degradation and their impact on perinatal outcomes. The primary aim of this study was to evaluate the performance of the Doppler at the time of diagnosis in predicting the outcome of pregnancies. The secondary aim was to evaluate the performance of Doppler performed at any time during pregnancy and studied independently in predicting outcome of pregnancies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 25, 2023

Completed
Last Updated

January 25, 2023

Status Verified

January 1, 2023

Enrollment Period

6 months

First QC Date

January 13, 2023

Last Update Submit

January 13, 2023

Conditions

Keywords

Fetal Growth Retardation, Doppler, perinatale outcome

Outcome Measures

Primary Outcomes (1)

  • evaluate the performance of the Doppler at the time of diagnosis in predicting the outcome of pregnancies

    during pregnancy (6 month per patient maximum)

Secondary Outcomes (1)

  • evaluate the performance of Doppler performed at any time during pregnancy and studied independently in predicting outcome of pregnancies

    during pregnancy (6 month per patient maximum)

Study Arms (2)

Early fetal growth restriction

Fetal growth restriction diagnosed before 32 SA

Other: Ultrasound

Late fetal growth restriction

Fetal growth restriction diagnosed after 32 SA

Other: Ultrasound

Interventions

Doppler mesure

Early fetal growth restrictionLate fetal growth restriction

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All the FGR of antenatal diagnosis, who were confirmed by an ultrasound made by a referring Doctor and involved in a specific management for FGR, during this period of 2 years were included

You may qualify if:

  • Fetal growth restriction of antenatal diagnosis

You may not qualify if:

  • Twin pregnancies, non-isolated IUGR, post-natal diagnosis of FGR and incomplete records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternite Regionale et Universitaire de Nancy

Nancy, Meurthe-et-moselle, 54000, France

Location

MeSH Terms

Conditions

Fetal Growth Retardation

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

January 13, 2023

First Posted

January 25, 2023

Study Start

June 1, 2022

Primary Completion

December 1, 2022

Study Completion

January 1, 2023

Last Updated

January 25, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations